Background and objective: Idiopathic pulmonary fibrosis (IPF) is increasingly diagnosed by clinical and computed tomography (CT) criteria; however, surgical lung biopsy (SLB) may still be required in patients who lack definite CT features of usual interstitial pneumonia (UIP). We reviewed a cohort of elderly patients who underwent SLB, to evaluate the benefit of SLB in diagnosing idiopathic interstitial pneumonia (IIP). Methods: We searched the pathology records of Mayo Clinic for ambulatory patients at least 75 years old, who underwent SLB between 2000 and 2012 for indeterminate IIP. Histologic slides were reviewed and clinical data were extracted from the record. Results: A total of 55 patients (35 male) were enrolled. Median (interquartile range) age was 77 (76-80) years. Forced vital capacity was 70 (61-76)% and diffusing capacity of the lungs for carbon monoxide was 48 (42-54)% of predicted. In total, 37 (67%) patients had IPF, including 61% of those with HRCT findings inconsistent with UIP. Thirty-day mortality was 10% and 90-day mortality was 15%. Conclusion: The high mortality rate of SLB complicates the risk-benefit analysis in elderly patients with IIP. The expected value of the SLB is probably highest when the HRCT features are inconsistent with UIP, due to the frequent (39%) retrieval of patterns other than UIP.
INTRODUCTION
Idiopathic pulmonary fibrosis (IPF), the most common idiopathic interstitial pneumonia (IIP), is increasingly diagnosed by integrating clinical and high-resolution computed tomography (HRCT) imaging data. 1 A surgical lung biopsy (SLB) may, however, still be required in patients who lack definite HRCT features of the usual interstitial pneumonia (UIP) pattern. In addition to the risks inherent in the thoracotomy or thoracoscopic access into the chest, SLB has also been associated with acute exacerbation of the underlying interstitial lung disease (ILD), with high morbidity and mortality rates. [2] [3] [4] Given that both the incidence of IPF and the morbidity of SLB increase with age, the clinical benefit of SLB requires careful consideration in the elderly.
We reviewed a cohort of patients aged 75 years or older who underwent diagnostic evaluation for IIP and then underwent SLB because the clinical-radiographical correlation failed to establish a confident diagnosis. We hypothesized that IPF is the most common diagnosis and we aimed to establish the post-operative mortality in this patient population.
METHODS
We searched the pathology records of Mayo Clinic in Minnesota and Arizona for ambulatory patients at least 75 years old who underwent SLB between 2000 and 2012 for IIP. Age, sex, pulmonary function (forced vital capacity (FVC) % predicted, total lung capacity %, diffusing capacity of the lungs for carbon monoxide %), smoking status (pack-years smoked and years quit), relevant medication exposures, presence of oesophageal reflux and connective tissue diseases, symptoms (cough and dyspnoea) and their duration and pre-biopsy diagnosis were extracted from the record. The HRCT images were reviewed and classified according to the American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines for UIP pattern. 1 The lobar origin(s) of the biopsies were recorded as 'upper' versus 'lower' (including the middle lobe and the lingula) versus 'upper and lower'. Histologic slides were retrieved and reviewed by two authors (B.T.L. and H.D.T.) with subspecialty expertise in pulmonary pathology. The clinical record, HRCT data and histopathology were reviewed by two authors (L.T.V. and J.R.) who established a final clinical-radiological-pathological diagnosis for the purposes of this analysis. The study was approved (#11-002933) by the Mayo Clinic Institutional Review Board.
Patient survival was calculated relative to the date of the surgical biopsy. The Social Security death index (updated to 19 March 2014) was last searched on 10 September 2015 for this project. Patients not found in the Social Security Administration (SSA) death index were listed as having survived to the later of two dates: their last clinic contact or 19 March 2014.
The statistical analysis was completed in the software environment R 5 using a variety of packages for added functionality. 6 Confidence intervals were computed using bootstrap with 10 000 replicates. 7 For the multivariate regression analysis, missing data were imputed through predictive mean matching using bootstrap. 8 
RESULTS

Baseline characteristics of patients
A total of 107 records were screened for this study, finding 43 subjects who were acutely ill inpatients at the time of the biopsy and were excluded. Nine other cases were excluded because they had thoracotomies for other indications (four aortic valve replacements, one coronary artery bypass grafting, two cases of nodule resection and two hiatal hernia repairs); the lung biopsy was added-on in these cases, with no indication in the record that they would have undergone a surgical biopsy otherwise. Fifty-five patients met inclusion criteria for this study; all had undergone thoracoscopy. A total of 38 (69%) patients had HRCT features inconsistent with UIP (Table 1) , while 13 patients (24%) had 'possible UIP' and 4 (7%) showed a HRCT pattern consistent with UIP (they all underwent SLB prior to the publication of the 2011 guidelines for the diagnosis of IPF 1 ). About two-thirds of patients were male and the median (interquartile range) age was 77 (76-80) years. Twenty-four patients were former smokers, with a cumulative exposure of 23 (14-45) pack-years. Smoking status was not adequately documented in the clinical record in one patient. Eleven patients had exposures to potentially causative medications (nine to statins and one each to amiodarone and methotrexate).
Symptoms
Dyspnoea was present in 82% of patients and cough was noted in 53%. The median duration of symptoms was 11 (4-18) months. Symptomatic oesophageal reflux was present in 27% patients.
Pulmonary function tests
The median FVC was 70 (61-76)% of predicted and diffusing capacity of the lungs for carbon monoxide (DL CO ) was 48 (42-54)% of predicted. Pre-operative FVC and DL CO data were missing in two and four patients, respectively.
Lobar origin of the samples
In 24 cases, biopsies sampled only the lower lobes, while four biopsies were restricted to the upper lobes. In the remaining 27 cases, both the upper and lower lobes were sampled.
Diagnoses
Thirty-seven patients (67%, 95% CI: 51-76%) had a final clinical-radiological-pathological diagnosis of IPF. Sixteen patients had other final clinical diagnoses (Table 2) , while the pulmonary disease of two patients remained unclassifiable.
All four subjects who had HRCT findings consistent with UIP had a compatible pattern on biopsy, leading to a diagnosis of IPF.
In the 13 patients with possible UIP on HRCT, 10 (77%, 95% CI: 38-92%) had a final diagnosis of IPF. The first items on the radiographic differential diagnostic lists in these patients were UIP/IPF (6 cases), nonspecific interstitial pneumonia (NSIP) (2), chronic hypersensitivity pneumonitis (CHP) (1), obliterative bronchiolitis (OB) (1) and unclassifiable (3) .
In the 38 patients with HRCT findings inconsistent with UIP, 23 (61%, 95% CI: 42-74%) had IPF. The radiographic differential diagnostic lists in these patients were led by UIP/IPF (8 cases), NSIP (11), CHP (5), COP (2), infection (2), vasculitis (2), eosinophilic pneumonia (1), adenocarcinoma (1) and OB (1), unclassifiable (5) .
When combining the groups with HRCT patterns inconsistent with, or showing possible UIP, 65% (95% CI: 49-75%) had IPF.
A multi-variable regression analysis of the factors associated with a final diagnosis of IPF (Table 3) found that male gender increased the odds of IPF 10-fold while an FVC decrease from 76% to 62% increased the odds of IPF 4-fold.
Survival
The 30-day mortality of the entire cohort was 9.7% (95% CI: 1.9-17%), while the 90-day mortality was 15.4% (95% CI: 5.8-25%). In patients with HRCT findings inconsistent with UIP, 30-day mortality was 8.6% (95% CI: 0-17%) and the 90-day mortality was 14.2% (95% CI: 3-26%) ( Table 4 ). The median survival for the entire cohort was 29 (10-48) months. Patients with IPF had a 30-and 90-day mortality of 14.7% (95% CI: 2.9-26%) and 20.7% (95% CI: 5.8-32%), respectively. Survival data were missing in three patients, who were foreign nationals without US Social Security records, and who were lost to clinical follow-up.
The cause of death in the patients who died within 90 days after surgery were acute exacerbations of IPF (four subjects, who died at 7, 11, 16 and 43 days postoperatively, respectively), acute myocardial infarct and sudden death (one each). The cause of death was unavailable in two patients, who died at 50 and 70 days post-operatively, and after having been discharged from the Mayo Clinic.
DISCUSSION
IIPs frequently pose a diagnostic challenge, with IPF being the most common diagnosis in this group of diffuse parenchymal lung diseases. The current diagnostic approach starts with clinical and HRCT data, and an HRCT pattern compatible with UIP is usually sufficient to diagnose IPF in the appropriate clinical context. 1, 9 When the radiological findings are indeterminate, a SLB may be required to allow the clinical-radiologicalpathologic integration that is the current paradigm in establishing the diagnosis in IIP; consequently, a study investigating the value of surgical biopsies in this context must assess both the utility of pathology samples and the risks associated with the surgical procedure. First, the pathology review has to provide incremental information, to refine the estimate of the Bayesian pretest probability of disease, in the face of recent literature 10 that suggests that the prevalence of UIP/IPF over the age of 70 is so high as to render SLB unhelpful, and indeed, unnecessary. However, the prevalence of UIP/IPF in our population was far lower than that in Fell et al.'s cohort. 10 Second, the estimate of the utility of SLB has to contend with the possibility that the Surgical biopsies for ILD in the elderly pathology pattern might be unclassifiable. Finally, the surgical mortality rate in the elderly is a non-trivial burden, as we found higher mortality rates than those typically reported in younger patients.
The correlation between HRCT and histopathology pattern continues to be a subject of great interest in IPF. Although radiographical honeycombing is present in most patients with pathologic UIP, 11, 12 the latter can also be diagnosed in patients with atypical HRCT patterns. An analysis of 241 patients from three IPFnet studies who had undergone both HRCT and a SLB found that 31% of subjects had an HRCT pattern inconsistent with UIP, 13 while others have found UIP on pathology in as many as 62% of patients with an HRCT pattern inconsistent with UIP. [14] [15] [16] An HRCT pattern of possible UIP was associated 94% of the time with a concordant histopathology in the ARTEMIS-IPF study; however, patients with collagen vascular diseases and occupational lung diseases were excluded and there were few alternative diagnoses in that cohort; therefore, these results may be closer to the upper bounds of the estimate of the positive predictive value for the possible UIP HRCT pattern. 17 In our cohort of subjects older than 75 years being evaluated for IIP in a referral centre, about two-thirds of patients had a diagnosis of IPF. When the HRCT suggested possible UIP, the probability of IPF was about 77%. However, in the group with HRCT patterns inconsistent with UIP, IPF was present only about 61% of the time and the high likelihood of encountering pathologic patterns other than UIP has clear diagnostic implications in this group of patients. Our findings differ from those in a cohort of 80 elderly (>70 years) patients from a prospective ILD trial, in which 66% of patients had diagnoses other than IPF. The variance may be, in part, due to the fact that only 9% of that cohort had a SLB. 18 Although typically diagnosed in the elderly 19 the incidence of IPF rises with age even within its target population; one study estimates that the incidence in 75-79 years-old is 1.92 times greater than the baseline rate in a population of patients aged 66-69 years, and the incidence rate ratio rises to 2.14 if age is greater than 80 years (compared to the baseline rate). 20 Our analysis did not show a significant association between IPF and either age (within the narrow range studied) or the smoking history, but suggests that male sex and the presence of a moderate restriction are associated with significant increases in the odds of diagnosing IPF.
Tissue sampling is often necessary to establish the diagnosis in patients when the HRCT pattern is incompatible with UIP or has features of possible UIP. While the role of SLB in diagnosing IIPs has been evolving over time, in large recent clinical trials of treatment modalities in IPF from 22% to 54% of patients had SLB to confirm the diagnosis. 21, 22 Many patients evaluated for SLB have multiple comorbidities and significant physiologic impairment, not least related to the underlying IIP being worked up. A review of 32 022 hospitalization records from US community hospitals between 2000 and 2011 and selected ICD-9-CM codes for ILD found an in-hospital mortality rate of 1.7% (95% CI: 1.5-1.9) for elective procedures. 23 The data set did not have information on 30-and 90-day mortality and the catchall diagnostic code 'post-inflammatory fibrosis' represented 80% of the cohort. In addition, the majority (61%) of patients was younger than 65 years, and had a slight female predominance, both features atypical for IPF. It is therefore likely that this mortality rate underestimates (perhaps substantially) the mortality of SLB in IPF. 23 Even in this group, patients with a provisional diagnosis of 'idiopathic pulmonary fibrosisclinical syndrome' were 3.71 times more likely to die in the hospital than those with post-inflammatory fibrosis. Although most studies report mortality rates under 5%, [24] [25] [26] one study 4 found a mortality of 17% (95% CI: 8.3-28.5%) and other studies 2, 3, [26] [27] [28] have raised concerns about the risk of acute exacerbation of the underlying IIP precipitated by the SLB procedure. The aggregate mortality rate in our study was 10% at 30 days and 15% at 90 days, with acute exacerbation of IPF being the most common cause of death.
Our study has several limitations, including its retrospective design and the fact that the study population is a non-random, and likely skewed (due to referral bias), subset of all elderly patients undergoing diagnostic workup for IIP, most of whom do not undergo SLB. Only about half of our cohort had biopsies taken from both the upper and lower lobes, which can affect the histopathology interpretation, considering that there is pathologic discordance between lobes in 13-26% of patients. 29, 30 Another limitation of our study is that histopathology samples were obtained exclusively through surgical procedures, whereas bronchoscopic cryobiopsies have an increasing role in providing tissue diagnosis during the workup of IIP. Due to its design, our study does not address the role and limitations of cryobiopsies in this elderly population. Our findings suggest that although SLB may be valuable in the diagnostic workup of select elderly patients with IIP and atypical HRCT patterns for UIP, the information gains of the biopsy come at the expense of higher mortality rates than those typically reported in the literature.
